Citaat | Rechtbank Den Haag 14 oktober 2020

Onder 2.24. Rechtbank Den Haag 14 oktober 2020

Een alinea uit Rechtbank Den Haag 14 oktober 2020, ECLI:NL:RBDHA:2020:10160.

For the avoidance of costs resulting from PI proceedings, we offer to withdraw our product from the listing in exchange for an undertaking from your client which acknowledges that they are liable for all damages, in the same manner as would be determined by a court in the Netherlands in such matters, arising from AstraZeneca's enforcement of EP (NL) 364 in the Netherlands against Sandoz, affiliated companies, and/or its customers in connection with Sandoz' generic sustained release quetiapine product since at least July 23, 2012. This undertaking will be governed by the laws of The Netherlands with exclusive jurisdiction in the Courts of The Hague, undersigned by a duly authorized person for your client, and returned to us no later than 12:00 on July 10, 2013.

Zelf controleren

Voor dit citaat hoeft niemand Bron op zijn woord te geloven. Het document dat rechtspraak.nl publiceerde, staat op https://bron.page/api/v1/blobs/cdaffb8fd5469161d3454e2ae6632b9097d48a53b75f944a5fe32fca849cd272. Wie het ophaalt en de SHA-256 ervan berekent, krijgt cdaffb8fd5469161d3454e2ae6632b9097d48a53b75f944a5fe32fca849cd272, en de alinea staat in dat document op bytes 23125 tot 23966.